Innov8 Labs x Aquila Bioscience. Advanced Anti-Blemish Serum

We're excited to launch at Cosmoprof Bologna in March 2025

The idea for this product came from an unexpected source: bioscience research aimed at protecting astronauts from pathogens in space. Recognising the rising global challenge of skin disorders and acne Aquila Bioscience and Innov8 Labs collaborated to incorporate the novel PCT into the Advanced Anti Blemish Serum. Through extensive R&D, the gel architecture emerged as the ideal vehicle preserving PCT stability while enabling optimal delivery and distribution across the skin. This biomimetic approach addresses the growing consumer demand for sustainable gentle alternatives to traditional treatments. Currently undergoing clinical validation this intelligent system represents a paradigm shift in acne care.

We are so excited to launch this product because it brings a completely new and effective solution to the acne care market. Originally developed for biodefence purposes to protect astronauts from potential infectious diseases during space flights, Aquila Bioscience's PCT has found a powerful new application in skincare. The innovation stems from the PCT technology itself. Through extensive study of evolutionary biology, the team discovered how pathogens use proteins and carbohydrates as 'anchors' to attach to human cells, whilst nature ingeniously counters with protective 'decoy' molecules that trap and expel these threats. The technology employs unique protein-carbohydrate complexes that function like molecular "Velcro," selectively capturing and removing pathogenic bacteria without disrupting the skin's beneficial microbiome. This biomimetic approach represents a paradigm shift in acne treatment, achieving 99.9% bacterial capture (in-vitro) through physical removal rather than harsh chemical intervention. It's also differentiated from competition due to the mechanism of action of PCT that has never been employed in this category before. Sustainable design features cold-process manufacturing and 96% naturally derived, biodegradable ingredients, housed in a recyclable mono-material airless pump with 30% PCR content, optimising both product stability and environmental responsibility.

Leveraging biomimetic technology inspired by natures defence mechanisms this innovative formula demonstrates 99 9 bacterial capture efficacy in vitro whilst delivering results Through its patent pending PCT system this product reduces blemishes and helps prevent future breakouts Users also experience visible improvements in skin clarity and texture This sophisticated formulation enriched with niacinamide also strengthens the skin barrier whilst maintaining beneficial flora Free from harsh actives alcohol and fragrance this pH balanced dermatologically tested treatment provides consistent results through gentle yet powerful technology. This intelligent system supports skin health particularly beneficial for blemish prone complexions seeking sustainable results without compromise.

Engineered protein-carbohydrate complexes are at the core of this serum, acting to target and remove acne-causing bacteria without disrupting the skin’s biological balance. The formula leverages biomimetic technology inspired by nature’s defense mechanisms – and bioscience research aimed at protecting astronauts from pathogens in space – to “capture” bacteria, reducing blemishes and helping to prevent future breakouts. The protein-carbohydrate complexes function like molecular "Velcro," selectively capturing and removing pathogenic bacteria without disrupting the skin's beneficial microbiome. The gel serum also contains niacinamide to strengthen the skin barrier whilst maintaining beneficial flora. The 96% naturally derived formula demonstrates 99.9% bacterial capture in in vitro tests, via physical removal rather than chemical intervention.

ACCREDITATIONS FDA Registration: Aquila Bioscience have been successfully registered as a foreign manufacturing facility for the ABD Device with the FDA under Owner/ Operator Number 10074735 NeoVirTech: French Laboratory of expertise has proven the efficiency of the ABD Device in its ability to capture and remove up to 99.99% of SARS CoV-2 from the human skin. PATENTS International Patent Application WIPO 2020/240027 A1. Device and method for decontamination / disinfection.

With the technology developed in a research-intensive university setting at University of Galway, Innov8 Labs and Aquila Bioscience understand the value of research and industry collaboration in bringing this disruptive innovation to market. Through strategic partnerships, we aim to emphasise both the scientific credibility and thought leadership behind this breakthrough technology whilst maximising its visibility across key industry channels. Our multi-channel promotions will include: Digital Leadership & B2B Engagement: Innov8 Labs and Aquila Bioscience will utilise LinkedIn and strategic digital platforms to establish the Advanced Anti-Blemish Serum as a pioneering innovation in skincare. We'll publish thought leadership content showcasing PCT technology and its broader applications, supported by consumer insights and industry trends. We will also run a targeted B2B strategy to connect with decision-makers in multinational businesses seeking next-generation skincare technologies. Digital Knowledge Hub: Both companies’ websites will serve as comprehensive B2B resource centres, providing detailed insights into the technology, clinical efficacy, and market applications. These platforms will feature scientific validation, case studies, and white papers, alongside a dedicated knowledge hub containing market trends and innovation insights, reinforcing both scientific credibility and commercial viability. Industry Presence: Our presence and exhibition stand at Cosmoprof Worldwide Bologna provides a global platform to showcase this innovation to industry leaders and R&D teams. Additionally, the Aquila team's expertise strongly positions us to engage at specialist dermatology and bioscience conferences, creating opportunities to connect with science-led companies and generate broader awareness. Scientific Collaboration: To reinforce the scientific credibility of the Advanced Anti-Blemish Serum, both companies will actively participate in beauty innovation summits and expert panels, engaging in discussions at the intersection of bioscience and skincare. Building on its university-led origins, the team will also endeavour to expand academic partnerships, further advancing bioscience-driven skincare innovations. Our goal is to ensure this breakthrough PCT technology makes a lasting global impact through evidence-based communications and strategic industry engagements.

Ingredient declaration: Aqua, Glycerin, Niacinamide, Caesalpinia Spinosa Gum/Ammonium AMPS Crosspolymer, Phenoxyethanol, Ethylhexylglycerin, Hydrolysed milk protein, Potassium phosphate, Sodium phosphate, Sodium Chloride, Potassium Chloride, Citric acid. This innovative gel serum is formulated with biomimetic actives inspired by nature’s defence mechanisms, designed to gently yet effectively target blemish-prone skin. The formulation includes natural and skin-friendly ingredients, with the key active being a biomimetic protein-carbohydrate complex that captures and removes impurities without disrupting the skin’s natural balance. The formulation is a cold-process emulsion, ensuring energy efficiency and minimising environmental impact. The formulation is 96% naturally derived, readily biodegradable, and carefully selected for its safety and efficacy, aligning with green principles. The product is housed in a fully recyclable, mono-material airless pump made entirely of polypropylene (PP), incorporating 30% post-consumer recycled (PCR) content. This packaging design ensures optimal product protection, precise dosing, and minimal waste while supporting a circular economy. The airless system also preserves the integrity of the formulation and extending product stability.

Environmental stewardship drives innovation and manufacturing at Innov8 Labs, where sustainability and ethical responsibility are fundamental to our business philosophy. Our cold-process manufacturing method significantly reduces energy consumption compared to traditional hot-process methods, while preserving the integrity of our active ingredients. We've set ambitious environmental targets, including a commitment to reduce our carbon footprint by 50% by 2027. This goal is supported by our ongoing transition to renewable energy solutions across our operations, marking a crucial step in our journey towards net zero. Our commitment extends to our cruelty-free status, reflecting our core value that beauty should never come at the cost of animal welfare. We maintain rigorous ethical sourcing practices across our supply chain, carefully selecting partners who share our values and commitment to responsible business practices. This dedication to responsibility is further exemplified in our product packaging, where we've implemented a mono-material approach. All our formulations prioritise naturally derived, biodegradable ingredients, carefully selected for their minimal environmental impact while maintaining optimal efficacy. Looking ahead, we're continuously exploring new ways to reduce our environmental impact, from expanding our use of renewable energy to investigating additional sustainable packaging solutions. At Innov8 Labs, we believe that scientific innovation must go hand in hand with environmental responsibility, creating products that deliver exceptional results while protecting our planet's future.

This technology meets evaluation criteria by bringing unprecedented scientific innovation to acne care. The groundbreaking PCT technology represents a fundamental advancement in skincare science, where sophisticated protein-carbohydrate complexes physically trap and remove bacteria through a unique lift and lock mechanism. This biomimetic approach delivers consistent results, directly fulfilling the innovation criteria through its novel mechanism of action and demonstrated performance. This advanced formula demonstrates exceptional efficacy while prioritising skin health. Free from common irritants including fragrance, alcohol, and harsh preservatives, it delivers reliable results for acne-prone skin. Rigorous testing confirms consistent performance under various conditions, meeting evaluation requirements for both safety and efficacy. The formulation's innovative delivery system ensures optimal bioavailability and skin compatibility. Quality assurance is embedded throughout production, with manufacture under both ISO13485 medical device and ISO22716 cosmetic GMP standards. This dual certification ensures exceptional consistency and safety, exceeding standard industry requirements. Our rigorous quality control processes guarantee that every batch meets the highest standards of performance and safety. Environmental responsibility is integrated across development and production. The cold-process manufacturing reduces energy consumption and waste, while 96% naturally derived, biodegradable ingredients minimise environmental impact. The innovative mono-material airless pump system, made from polypropylene (PP) with 30% PCR content, demonstrates our commitment to sustainability from formula to packaging. This comprehensive approach to environmental stewardship extends throughout the supply chain, from ingredient sourcing to final packaging considerations. By merging biotech innovation with sustainable practices, this breakthrough establishes new benchmarks in acne treatment efficacy, safety, and environmental responsibility. The result is a premium skincare solution that advances industry standards while meeting modern consumer demands for both performance and sustainability, delivering measurable results through revolutionary science.

For more information on the disruptive science behind this product, please visit Aquila Bioscience at https://aquilabioscience.com/. To understand the manufacturing and R&D expertise driving this innovation, please visit Innov8 Labs at www.weareinnov8labs.com. As a leader in full-service beauty manufacturing, Innov8 Labs specialises in breakthrough innovations, new product development, and scalable solutions. Connect with the company on LinkedIn at http://linkedin.com/company/weareinnov8labs to stay updated on our latest trends and product advancements.

Licensing and pricing details are available through consultation with Innov8 Labs. This product is designed for Gen Z and Millennials, increasingly educated demographics that values efficacy, microbiome health, and results-driven skincare. With acne rates rising globally, consumers seek gentle alternatives to traditional treatments that often rely on strong chemicals or antibiotics, compromising skin barriers and leading to long-term sensitivity, dryness, and inflammation. Globally, 51% of Gen Z prioritise acne treatment, while 74% of Millennials seek even skin tone, highlighting a demand and real market need for scientifically advanced, skin-friendly formulations that actually work.